Cargando…

A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients

Although several models have been developed to predict the probability of Gleason sum upgrading between biopsy and radical prostatectomy specimens, most of these models are restricted to prostate-specific antigen screening-detected prostate cancer. This study aimed to build a nomogram for the predic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jin-You, Zhu, Yao, Wang, Chao-Fu, Zhang, Shi-Lin, Dai, Bo, Ye, Ding-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sun Yat-sen University Cancer Center 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026544/ https://www.ncbi.nlm.nih.gov/pubmed/24559852 http://dx.doi.org/10.5732/cjc.013.10137

Ejemplares similares

Development and External Validation of a Nomogram Predicting the Probability of Significant Gleason Sum Upgrading among Japanese Patients with Localized Prostate Cancer
por: Imamoto, Takashi, et al.
Publicado: (2011)

Predicting Gleason sum upgrading from biopsy to radical prostatectomy pathology: a new nomogram and its internal validation
por: Wang, Xiaochuan, et al.
Publicado: (2021)

Predictive Factors of Gleason Score Upgrading in Localized and Locally Advanced Prostate Cancer Diagnosed by Prostate Biopsy
por: Moon, Seung Jin, et al.
Publicado: (2010)

Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation
por: He, Biming, et al.
Publicado: (2016)

A high high-density lipoprotein level is associated with Gleason score upgrade in Chinese patients diagnosed with high-grade prostate carcinoma
por: Lyu, Jingcheng, et al.
Publicado: (2023)

Validation of an MRI-based prostate cancer prebiopsy Gleason score predictive nomogram
por: Lee, Adrianna Jiaying, et al.
Publicado: (2022)

Role of inflammatory factors in prediction of Gleason score and its upgrading in localized prostate cancer patients after radical prostatectomy
por: Wang, Shuo, et al.
Publicado: (2023)

Higher Prostate Weight Is Inversely Associated with Gleason Score Upgrading in Radical Prostatectomy Specimens
por: Reis, Leonardo Oliveira, et al.
Publicado: (2013)

Is Small Prostate Volume a Predictor of Gleason Score Upgrading after Radical Prostatectomy?
por: Chung, Mun Su, et al.
Publicado: (2013)

CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate Cancer
por: Qin, Xiao-Ping, et al.
Publicado: (2022)

Self‐Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy
por: Grizzle, William E., et al.
Publicado: (2019)

Analysis of risk factors for Gleason score upgrading after radical prostatectomy in a Chinese cohort
por: Zhang, Baoling, et al.
Publicado: (2021)

Predicting Prostate Cancer Upgrading of Biopsy Gleason Grade Group at Radical Prostatectomy Using Machine Learning-Assisted Decision-Support Models
por: Liu, Hailang, et al.
Publicado: (2020)

Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer
por: Novak, Vojtech, et al.
Publicado: (2020)

Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens
por: Kim, Hwanik, et al.
Publicado: (2021)

Differences in survival of prostate cancer Gleason 8–10 disease and the establishment of a new Gleason survival grading system
por: Zhou, Yuan, et al.
Publicado: (2020)

Influence of Active Surveillance on Gleason Score Upgrade and Prognosis in Low- and Favorable Intermediate-Risk Prostate Cancer
por: Hu, Xuanhan, et al.
Publicado: (2022)

From Cognitive MR-Targeted Fusion Prostate Biopsy to Radical Prostatectomy: Incidence and Predictors of Gleason Grade Group Upgrading in a Chinese Cohort
por: Yan, Huaqing, et al.
Publicado: (2022)

The Impact of Pathologic Upgrading of Gleason Score 7 Prostate Cancer on the Risk of the Biochemical Recurrence after Radical Prostatectomy
por: Park, Juhyun, et al.
Publicado: (2018)

Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi‐institutional analysis
por: Barsky, Andrew R., et al.
Publicado: (2020)

Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?
por: Pham, Duc Minh, et al.
Publicado: (2020)

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance
por: Tomer, Anirudh, et al.
Publicado: (2020)

The prevalence and risk factors of upgrading of Gleason grade group between transrectal ultrasound prostate biopsy and prostatectomy specimens
por: Promsen, Worapong, et al.
Publicado: (2023)

Factors predicting Gleason score 6 upgrading after radical prostatectomy
por: Milonas, Daimantas, et al.
Publicado: (2011)

Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage
por: Lee, Seung Wook, et al.
Publicado: (2015)

Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
por: Ro, Yun Kwan, et al.
Publicado: (2012)

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
por: Press, Benjamin H., et al.
Publicado: (2022)

Old men with prostate cancer have higher risk of Gleason score upgrading and pathological upstaging after initial diagnosis: a systematic review and meta-analysis
por: Wang, Xiaochuan, et al.
Publicado: (2021)

Prostate Cancer in Patients with Metabolic Syndrome Is Associated with Low Grade Gleason Score When Diagnosed on Biopsy
por: Jeon, Kyoung Pil, et al.
Publicado: (2012)

Prediction model of gleason score upgrading after radical prostatectomy based on a bayesian network
por: Wang, Guipeng, et al.
Publicado: (2023)

miR-145-5p: A Potential Biomarker in Predicting Gleason Upgrading of Prostate Biopsy Samples Scored 3+3=6
por: Wang, Tao, et al.
Publicado: (2021)

Predictive efficacy of the 2014 International Society of Urological Pathology Gleason grading system in initially diagnosed metastatic prostate cancer
por: Sun, Guang-Xi, et al.
Publicado: (2017)

Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population
por: Zhou, Feng, et al.
Publicado: (2016)

Does the Time From Biopsy to Radical Prostatectomy Affect Gleason Score Upgrading in Patients With Clinical T1c Prostate Cancer?
por: Eroglu, Muzaffer, et al.
Publicado: (2014)

The Use of Exome Genotyping to Predict Pathological Gleason Score Upgrade after Radical Prostatectomy in Low-Risk Prostate Cancer Patients
por: Oh, Jong Jin, et al.
Publicado: (2014)

Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer
por: Kayano, Paulo Priante, et al.
Publicado: (2018)

The gut microbiota associated with high‐Gleason prostate cancer
por: Matsushita, Makoto, et al.
Publicado: (2021)

Gleason 6 prostate cancer: That which cannot be named
por: Burke, Harry B.
Publicado: (2022)

Nomograms Predict Survival Advantages of Gleason Score 3+4 Over 4+3 for Prostate Cancer: A SEER-Based Study
por: Zhu, Xin, et al.
Publicado: (2019)

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
por: Wang, Hanfeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cbvvi4jsf8pm3snr6m5mm204vc